Pharmaceutical group · United States
Vivus
A group of 4 companies with 13 medicines in 4 countries.
Group structure
4 companies in 2 countries
Netherlands1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PANCREASE MT 1043750 unit + 10500 unit + 25000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1988 |
| PANCREASE MT 1670000 unit + 16800 unit + 40000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1988 |
| PANCREASE MT 210850 unit + 2600 unit + 6200 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 2020 |
| PANCREASE MT 2061000 unit + 21000 unit + 37000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 2020 |
| PANCREASE MT 417500 unit + 4200 unit + 10000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1988 |
| PANCREAZE149,900usp units; 37,000usp units; 97,300usp units | 15,200usp units; 2,600usp units; 8,800usp units | 24,600usp units; 4,200usp units; 14,200usp units | 61,500usp units; 10,500usp units; 35,500usp units | 83,900usp units; 21,000usp units; 54,700usp units | 98,400usp units; 16,800usp units; 56,800usp units · Capsule, delayed release | Pancrelipase (amylase, Lipase, Protease | United States | Marketed | 2010 |
| Qsiva 11,25 mg/69 mg tvrde kapsule s prilagođenim oslobađanjemKapsula s prilagođenim oslobađanjem, tvrda | Phentermine, Topiramate | Croatia | Not marketed | 2025 |
| Qsiva 15 mg/ 92 mg tvrde kapsule s prilagođenim oslobađanjemKapsula s prilagođenim oslobađanjem, tvrda | Phentermine, Topiramate | Croatia | Not marketed | 2025 |
| Qsiva 3,75 mg/23 mg tvrde kapsule s prilagođenim oslobađanjemKapsula s prilagođenim oslobađanjem, tvrda | Phentermine, Topiramate | Croatia | Not marketed | 2025 |
| Qsiva 7,5 mg/46 mg tvrde kapsule s prilagođenim oslobađanjemKapsula s prilagođenim oslobađanjem, tvrda | Phentermine, Topiramate | Croatia | Not marketed | 2025 |
| QSYMIA11.25mg base; 69mg | 15mg base; 92mg | 3.75mg base; 23mg | 7.5mg base; 46mg · Capsule, extended release | Phentermine, Topiramate | United States | Marketed | 2012 |
| STENDRA100mg | 200mg | 50mg · Tablet | Avanafil | United States | Marketed | 2012 |
| Qsiva | Phentermine, Topiramate | EU (EMA) | Refused |